Table 3.
Reported rates of various endocrine-related symptoms according to group, as well as estimated general prevalence rates.
| Endocrine Symptomology | ASD (N = 85) |
ASD/EDS (N = 20) |
General Prevalence |
|---|---|---|---|
| Adult Acne | 21% | 35% | 35% in women ages 30–39 [36] |
| Amenorrhea | 39% | 45% | 4.6% in women ages 15–44 [37] |
| Diabetes/Insulin Resistance | 6% | 10% | 7.9% in adults [38] |
| Dysmenorrhea | 28% | 85% * | 2–29% in adult women [39] |
| Endometriosis | 5% | 30% * | 4% in women [40] |
| High LDL Cholesterol | 14% | 30% | 28% in adults [41] |
| Hirsutism | 19% | 30% | 10% in adult women [42] |
| Hypertension | 14% | 20% | 29.1% in adults [43] |
| Infertility | 8% | 15% | 6% [44] |
| Irregular Menstruation | 27% | 55% | 18.2% in adult women [45] |
| Overweight/Obesity | 36% | 45% | 70.7% aged 20+ years [46] |
| Polycystic Ovary Syndrome (PCOS) | 8% | 25% | 7.3% in adult women [47] |
| Premenstrual Dysphoric Disorder (PMDD) | 21% | 30% | 3–8% of premenopausal women [48] |
| Severe Teen Acne | 14% | 45% * | 12.1% in males and females aged 17 [49] |
| Uterine Fibroids | 9% | 5% | 4.5–9.8% in adult women aged 40–49 [50] |
* indicates a significant difference between groups.